To determine whether STEAP4 regulated chemotherapy resistance of HCC, GSEA analysis showed that low STEAP4 expression was positively correlated with cisplatin resistance (Fig. 2a), suggesting STEAP4 might regulate chemotherapy resistance. The gene discussed is STEAP4; the disease is hepatocellular carcinoma.